Cancer incidence among workers with blood lead measurements in two countries

30.09.2019

IOM scientists Will Mueller, Peter Ritchie and Prof Damien McElvenny are amongst the co-authors of a paper entitled "Cancer incidence among workers with blood lead measurements in two countries". published in "Occupational and Environmental Medicine"

Objective Study carcinogenicity of inorganic lead, classified as ‘probably carcinogenic’ to humans by the International Agency for Research on Cancer (brain, lung, kidney and stomach).

Methods We conducted internal and external analyses for cancer incidence in two cohorts of 29 874 lead-exposed workers with past blood lead data (Finland, n=20 752, Great Britain=9122), with 6790 incident cancers. Exposure was maximum measured blood lead.

Results The combined cohort had a median maximum blood lead of 29 μg/dL, a mean first blood lead test of 1977, and was 87% male. Significant (p<0.05) positive trends, using the log of maximum blood lead, were found for brain cancer (malignant), Hodgkin’s lymphoma, lung cancer and rectal cancer, while a significant negative trend was found for melanoma. Borderline significant positive trends (0.05≤p≤0.10) were found for oesophageal cancer, meningioma and combined malignant/benign brain cancer. Categorical analyses reflected these trends. Significant interactions by country were found for lung, brain and oesophageal cancer, with Finland showing strong positive trends, and Great Britain showing modest or no trends. Larynx cancer in Finland also showed a positive trend (p=0.05). External analyses for high exposure workers (maximum blood lead >40 μg/dL) showed a significant excess for lung cancer in both countries combined, and significant excesses in Finland for brain and lung cancer. The Great Britain data were limited by small numbers for some cancers, and limited variation in exposure.

Conclusions We found strong positive incidence trends with increasing blood lead level, for several outcomes in internal analysis. Two of these, lung and brain cancer, were sites of a priori interest.

The full text of the paper is available here.

 

  • IOMworld Posted: 2 days ago
    Join us at Healthcare Estates Conference, Manchester Central, on 4 & 5 October 2022. Register for your free visitor… https://t.co/ymyxuoaHzJ
  • IOMworld Posted: 2 days ago
    As the Safety, Health & Wellbeing Live conference has now come to an end, we wish to thank everyone for visiting ou… https://t.co/xHmpuiDNK8
  • IOMworld Posted: 3 days ago
    IOM's Nathan Baker and David Flower talking today at @SHWLive where they are sharing their insights on ‘What long t… https://t.co/UzTL5SAziu
  • IOMworld Posted: 3 days ago
    Day 2 of the Safety, Health & Wellbeing Live conference is well underway. Come and visit our live wall at stand 120… https://t.co/2TJuf3yCtt
  • IOMworld Posted: 4 days ago
    The @SHWLive event in now underway at Farnborough International Exhibition & Conference Centre. Come and visit us a… https://t.co/BWcN9margL
  • IOMworld Posted: 10 days ago
    Today! IOM’s Miranda Loh will be speaking at the Understanding Air Quality for Health in Different Environments eve… https://t.co/tfN8IYgHQb
  • IOMworld Posted: 11 days ago
    Join us at the @SHWLive event, Farnborough International, on 28 & 29 September 2022. Register for your free ticket… https://t.co/jb7dFHMt9v
  • IOMworld Posted: 17 days ago
    We are delighted that IOM'S Miranda Loh will be speaking at the @BreathingCity event on Understanding Air Quality f… https://t.co/qo5yv7Tcar
  • IOMworld Posted: 18 days ago
    The Safety in Construction show is now in full swing at Holywell Park Conference Centre, Loughborough. Come & visit… https://t.co/Q43O0EzEhe
  • IOMworld Posted: 18 days ago
    Today! Join IOM’s Miranda Loh at 12:45 in the Presentation Theatre at the Safety in Construction show where she wil… https://t.co/qgne19yG7W